Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....